REG - Spire Healthcare Grp - Director/PDMR Shareholding
10/04/2025 15:30
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250410:nRSJ5709Ea&default-theme=true
RNS Number : 5709E Spire Healthcare Group PLC 10 April 2025
10 April 2025
Spire Healthcare Group plc (the Company)
Exercise of Executive Share Plan awards
On 7 April 2025, the Executive Directors of the Company, exercised vested
Executive Share Plan awards as follows:
(1) Justin Ash exercised both his:
· Long Term Incentive Plan award in the Company that were granted on 6
April 2020 (the 2020 LTIP award). 2020 LTIP awards were subject to certain
performance metrics that were measured over a three-year period and full
details of the outcomes of these were reported in the Company's 2022 Annual
Report and Accounts. On vesting in April 2023, the 2020 LTIP awards were
subject to a further two-year holding period which ended in April 2025; and
· Deferred Share Bonus Plan awards that were granted on 14 March 2022
(the 2022 DSBP award). 2022 DSBP awards were subject to a three-year holding
period which ended on the third anniversary of the award being made; and
(2) Harbant Samra exercised his Long Term Incentive Plan award in the
Company that were granted on 14 March 2022 (the 2022 LTIP award). 2022 LTIP
awards were subject to certain performance metrics that were measured over a
three-year period and full details of the outcomes of these were reported in
the Company's 2024 Annual Report and Accounts.
Following the exercise by the Directors of these awards over ordinary shares
in the Company and after the satisfaction of taxes due, both decided to retain
the balance of ordinary shares as follows:
Share plan and type of award Shares vested and exercised Shares retained following satisfaction of taxes due
Justin Ash 2020 LTIP (in the form of nil-cost options) 753,866 399,548
Justin Ash 2022 DSBP (in the form of nil-cost options) 95,007 50,353
Total number of shares retained 449,901
Following the transactions, Justin Ash holds 1,298,641 ordinary shares in the
Company.
Share plan and type of award Shares vested and exercised Shares retained following satisfaction of taxes due
Harbant Samra 2022 LTIP (in the form of nil-cost options) 34,671 18,375
Total number of shares retained 18,375
Following the transactions, Harbant Samra holds 53,259 ordinary shares in the
Company.
Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justinian Joseph Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan.
Following the exercise by Mr Ash of his award over 753,866 ordinary shares and
after the satisfaction of taxes due, a balance of 399,548 ordinary shares were
transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 753,866
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2025-04-07
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justinian Joseph Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Deferred Share Bonus Plan.
Following the exercise by Mr Ash of his award over 95,007 ordinary shares and
after the satisfaction of taxes due, a balance of 50,353 ordinary shares were
transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 95,007
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2025-04-07
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Harbant Singh Samra
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan.
Following the exercise by Mr Samra of his award over 34,671 ordinary shares
and after the satisfaction of taxes due, a balance of 18,375 ordinary shares
were transferred to him which he has retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 34,671
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2025-04-07
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDSCBBDGUGRecent news on Spire Healthcare
See all newsREG - Spire Healthcare Grp - Director/PDMR Shareholding
AnnouncementREG - Spire Healthcare Grp - Annual Financial Report
AnnouncementREG - Spire Healthcare Grp - Acquisition of Acorn Occupational Health Limited
AnnouncementREG - Spire Healthcare Grp - Block listing Interim Review
AnnouncementREG - Spire Healthcare Grp - Director/PDMR Shareholding
Announcement